ASH 2011 Conference Coverage

Decision Support and Shared Decision Making Help Patients Choose Plan for Low-Risk Prostate Cancer

Using an online decision-support tool led to most men with low-risk prostate cancer choosing active surveillance with less conflict about their decision.

Comprehensive Mental Health Screening Recommended for Some Childhood Cancer Survivors

Although most adolescent survivors of childhood cancer have no reported psychological symptoms, those who do often have multiple symptoms and distinct symptom profiles.

USPSTF: Evidence Lacking to Recommend Full-body Skin Cancer Screens

New report doesn't change Task Force's prior statement on skin cancer screening issued in 2009

Advanced Cancer Patients Often Unaware That They Are More Optimistic About Their Prognosis Than Their Oncologists

Most patients with advanced cancer report far more optimistic expectations for survival prognosis than their oncologists because patients misunderstand their oncologists' clinical judgment.

Transforming the Care of Patients With Thyroid Cancer

There were no effective therapeutic options for advanced thyroid cancer until 5 years ago.

VP Biden Talks About the Role of CancerLinQ at ASCO 2016

At the 2016 ASCO meeting, Vice President Joe Biden spoke about his vision for comprehensive data-sharing as part of the Cancer MoonShot initiative.

Survey Highlights Barriers to Global Data Sharing

Funding, informatics system, clinical data capture, and European data protection legislation were considered the greatest barriers to effective data sharing.

Immunotherapy Combination Is Effective in Colorectal Cancer

Cbimetinib and atezolizumab was well tolerated and demonstrated encouraging clinical activity in microsatellite stable colorectal cancer (CRC).

Monoclonal Antibody Shows Promise in Aggressive R/R Adult T-cell Leukemia/Lymphoma

Mogamulizumab induced an encouraging response rate in patients with relapsed/refractory adult T-cell leukemia/lymphoma.

Double Autologous HCT Improves Outcomes in High-risk Pediatric Neuroblastoma

Adding a second autologous hematopoietic cell transplantation (HCT) to standard therapy improves outcomes for pediatric patients with high-risk neuroblastoma.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs